← Holders
Deerfield Management Company, L.P.
What Deerfield Management Company, L.P. reported holding on Form 13F for the quarter ended Sep 30, 2026.
CIK 1009258 · Filed Nov 16, 2026
- Positions
- 77
- Reported value
- $6.5B
- Opened
- 16
- Closed
- 21
- Other managers included
- 1
Values are as the managers reported them, in dollars.Open the Form 13F on SEC EDGAR
Quarters on file
- Sep 30, 2025$6.6B152 positions
- Dec 31, 2025$7.8B150 positions
- Mar 31, 2026$8.5B82 positions
- Jun 30, 2026$9.6B82 positions
- Sep 30, 2026$6.5B77 positions
| Security | Shares | Change | Value | Of portfolio |
|---|---|---|---|---|
RVMDRevolution Medicines, Inc. | 2.1M | −11.2% | $436M | 6.7% |
BROOKDALE SR LIVING INCNOTE 3.500%10/1 | 306.9M | New | $425.6M | 6.6% |
CNCCentene Corp | 4.9M | ±0% | $304.5M | 4.7% |
UTHRUnited Therapeutics Corp | 540.6K | +18.3% | $292.9M | 4.5% |
PRAXPraxis Precision Medicines, Inc. | 963.4K | ±0% | $280.6M | 4.3% |
REVOLUTION MEDICINES INCNOTE 0.500% 5/0 | 200M | ±0% | $257.8M | 4% |
GMABGenmab A/S | 6.9M | ±0% | $244.9M | 3.8% |
ARROWHEAD PHARMACEUTICALS INNOTE 1/1 | 200M | New | $205.5M | 3.2% |
VTRSViatris Inc | 10.9M | −45.9% | $193.8M | 3% |
COGTCogent Biosciences, Inc. | 6M | +19.0% | $190.7M | 2.9% |
CELCCelcuity Inc. | 2.4M | +65.2% | $190.7M | 2.9% |
LEGNLegend Biotech Corp | 8.1M | ±0% | $161.9M | 2.5% |
VERAVera Therapeutics, Inc. | 4.3M | +10.8% | $140.1M | 2.2% |
TNGXTango Therapeutics, Inc. | 5.2M | +23.6% | $129.2M | 2% |
BCRXBiocryst Pharmaceuticals Inc | 15.5M | +2.6% | $129M | 2% |
BKDBrookdale Senior Living Inc. | 11.6M | ±0% | $126M | 1.9% |
BMRNBioMarin Pharmaceutical Inc | 2M | +51.9% | $121.5M | 1.9% |
IONSIonis Pharmaceuticals Inc | 2.7M | +34.4% | $118.8M | 1.8% |
LRMRLarimar Therapeutics, Inc. | 35.6M | ±0% | $113.8M | 1.8% |
NAMSNewAmsterdam Pharma Co N.V. | 4.3M | −0.2% | $103.5M | 1.6% |
MLYSMineralys Therapeutics, Inc. | 4M | ±0% | $99.5M | 1.5% |
CELCUITY INCNOTE 0.250% 8/0 | 100M | ±0% | $96.5M | 1.5% |
BSXBoston Scientific Corp | 2.1M | +62.4% | $93.2M | 1.4% |
CHEChemed Corp | 182K | +506.7% | $91.9M | 1.4% |
INSPInspire Medical Systems, Inc. | 1.3M | ±0% | $90M | 1.4% |
TEMPUS AI INCNOTE 0.750% 7/1 | 70M | New | $88.2M | 1.4% |
ZENAS BIOPHARMA INCNOTE 2.500% 4/0 | 67.2M | New | $85.7M | 1.3% |
BIOBio-Rad Laboratories, Inc. | 226.1K | ±0% | $85.4M | 1.3% |
PHVSPharvaris N.V. | 2.6M | −23.3% | $82.2M | 1.3% |
DNTHDianthus Therapeutics, Inc. | 914K | −18.8% | $80.5M | 1.2% |
IDYAIDEAYA Biosciences, Inc. | 2M | −26.2% | $77M | 1.2% |
SNDXSyndax Pharmaceuticals Inc | 3.8M | ±0% | $71.1M | 1.1% |
SVRASavara Inc | 13.6M | ±0% | $70M | 1.1% |
CERTCertara, Inc. | 7.5M | ±0% | $69.1M | 1.1% |
ACHCAcadia Healthcare Company, Inc. | 2.5M | −44.8% | $68.6M | 1.1% |
IONIS PHARMACEUTICALS INCNOTE 1.750% 6/1 | 60M | New | $66M | 1% |
AHCOAdaptHealth Corp. | 11.5M | ±0% | $64.7M | 1% |
ALIGNMENT HEALTHCARE INCNOTE 4.250%11/1 | 61M | New | $61.1M | 0.9% |
PBLSParabilis Medicines, Inc. | 1.9M | ±0% | $60.7M | 0.9% |
XENEXenon Pharmaceuticals Inc. | 1.6M | ±0% | $60.1M | 0.9% |
ARWRArrowhead Pharmaceuticals, Inc. | 843.1K | −39.3% | $55.2M | 0.9% |
NVSTEnvista Holdings Corp | 2.2M | ±0% | $51.9M | 0.8% |
STOKStoke Therapeutics, Inc. | 1.8M | ±0% | $47.4M | 0.7% |
ZTSZoetis Inc. | 632K | New | $44.1M | 0.7% |
LIVANOVA PLCNOTE 2.500% 3/1 | 34.3M | New | $44M | 0.7% |
IRONDisc Medicine, Inc. | 657K | ±0% | $43M | 0.7% |
BBNXBeta Bionics, Inc. | 1.9M | +43.8% | $36.1M | 0.6% |
GPCRStructure Therapeutics Inc. | 1.1M | ±0% | $34M | 0.5% |
SPRYARS Pharmaceuticals, Inc. | 7.5M | ±0% | $32.3M | 0.5% |
BLTEBelite Bio, Inc | 190K | −46.8% | $32.3M | 0.5% |
COOCooper Companies, Inc. | 557K | New | $31.5M | 0.5% |
BLSMBlossomHill Therapeutics, Inc. | 1.4M | New | $27M | 0.4% |
ODTXOdyssey Therapeutics, Inc. | 1M | ±0% | $23.2M | 0.4% |
TNDMTandem Diabetes Care Inc | 1.4M | New | $22.7M | 0.4% |
STLNStarling Oncology, Inc. | 3.4M | ±0% | $21.2M | 0.3% |
AVLNAvalyn Pharma Inc. | 731K | ±0% | $20.8M | 0.3% |
ALMRAlamar Biosciences, Inc. | 600K | ±0% | $20.4M | 0.3% |
TYRATyra Biosciences, Inc. | 732.4K | −28.0% | $16M | 0.2% |
FHTXFoghorn Therapeutics Inc. | 4.4M | ±0% | $15.7M | 0.2% |
VOGXVogenx, Inc. | 635.7K | New | $14.5M | 0.2% |
EMBCEmbecta Corp. | 2.5M | ±0% | $14.3M | 0.2% |
BBOTBridgeBio Oncology Therapeutics, Inc. | 3.1M | −35.8% | $12.9M | 0.2% |
NEOGENOMICS INCNOTE 0.250% 1/1 | 13M | New | $12.3M | 0.2% |
DRUGBright Minds Biosciences Inc. | 236.3K | −16.5% | $11.8M | 0.2% |
MNPRMonopar Therapeutics | 137.6K | −57.5% | $11M | 0.2% |
ALHCAlignment Healthcare, Inc. | 1.2M | New | $9.6M | 0.1% |
ADAGAdagene Inc. | 2.7M | ±0% | $8.5M | 0.1% |
COAGHemab Therapeutics Holdings, Inc. | 275K | ±0% | $8.5M | 0.1% |
ETRAElectra Therapeutics, Inc. | 700K | New | $7.9M | 0.1% |
ANNXAnnexon, Inc. | 583.9K | ±0% | $2.5M | 0.1% |
ALECAlector, Inc. | 1.1M | ±0% | $2M | 0.1% |
EWEdwards Lifesciences Corp | 13.7K | ±0% | $1.2M | 0.1% |
NAMSWNewAmsterdam Pharma Co N.V. | 92.8K | ±0% | $1.2M | 0.1% |
MIRMMirum Pharmaceuticals, Inc. | 6K | ±0% | $515.2K | 0.1% |
HUMHumana Inc | 917 | ±0% | $349.9K | 0.1% |
STLNWStarling Oncology, Inc. | 1.3M | New | $61K | 0.1% |
PMVPPMV Pharmaceuticals, Inc. | 8.8K | ±0% | $14.7K | 0.1% |